Abstract
Background: MDA-MB-231 is a Triple-Negative Breast Cancer (TNBC) cell line, which is resistant to tyrosine kinase inhibitors, such as lapatinib. Lapat......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
